Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Endo

- PMLiVE

US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan

The Sackler family will pay the amount over 18 years to victims of addiction and US states

- PMLiVE

UK to add addiction warnings to opioids as use soars

Codeine-related deaths doubled in a decade

- PMLiVE

FDA panel backs Indivior’s drug to fight opioid addiction

The former RB pharma unit hopes for sales in the $1bn region

- PMLiVE

Endo faces industry-first FDA call to pull its opioid painkiller

Misuse of Opana ER has been associated with a ‘serious’ HIV and hep C outbreaks

- PMLiVE

Endo buys Par for $8bn as M&A mania marches on

Acquisitionwill make Endo the fifth largest generics company in the US

- PMLiVE

Valeant raises offer for Salix; rival Endo bows out

Has increased bid to $173 per share in cash

- PMLiVE

Endo tries to ride out Valeant with $15.7bn bid for Salix

Around $1.2bn more than rival bid

- PMLiVE

Endo to acquire Auxilium for $2.6bn

Puts end to takeover deal for QLT

- PMLiVE

Endo’s $2.2bn bid for Auxilium Pharma could thwart QLT deal

Auxilium in the $345m process of acquiring Canadian biotech company

- PMLiVE

Endo opts for Ogilvy PR

Agency will provide PR support for Endo’s men’s health and pain management business

- PMLiVE

Endo builds pain management business

Agrees $105m deal to acquire NuPathe

- PMLiVE

Endo agrees $1.6bn deal to buy Paladin Labs

Gives company access to Canada and emerging markets

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links